Global Pharmaceutical CDMO Competitive Landscape Professional Research Report 2024

Research Summary

A Pharmaceutical Contract Development and Manufacturing Organization (CDMO) is a specialized service provider that offers comprehensive support to pharmaceutical and biotechnology companies in the development, manufacturing, and commercialization of drug products. CDMOs serve as strategic partners, providing expertise and infrastructure for various stages of the drug development process, including formulation development, analytical testing, clinical trial manufacturing, and commercial-scale production. These organizations play a crucial role in the pharmaceutical industry by offering flexible and cost-effective solutions, enabling companies to outsource specific aspects of their drug development and manufacturing processes. Pharmaceutical CDMOs contribute to accelerating time-to-market, reducing development costs, and ensuring compliance with regulatory standards, allowing pharmaceutical companies to focus on research, innovation, and core competencies.

According to DIResearch's in-depth investigation and research, the global Pharmaceutical CDMO market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Pharmaceutical CDMO include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton, Piramal, Strides Pharma, NextPharma, Famar, Jubilant, Alcami, Euroapi, Eurofins, Avid Bioservices, BioVectra, CPL etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Pharmaceutical CDMO. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pharmaceutical CDMO market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pharmaceutical CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pharmaceutical CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Pharmaceutical CDMO Include:

Lonza

Catalent

Thermo Fisher Scientific

Samsung Biologics

Fareva

WuXi AppTech

WuXi Biologics

Siegfried

FUJIFILM Diosynth Biotechnologies

Asymchem

Pfizer CentreOne

Delpharm

Recipharm

AGC Pharma Chemicals

Boehringer Ingelheim

Vetter

Curia

Aenova

Porton

Piramal

Strides Pharma

NextPharma

Famar

Jubilant

Alcami

Euroapi

Eurofins

Avid Bioservices

BioVectra

CPL

Pharmaceutical CDMO Product Segment Include:

API CDMO

FDF CDMO

Packaging CDMO

Clinical CDMO

Pharmaceutical CDMO Product Application Include:

Chemical Pharmaceutical

Biopharmaceutical

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Pharmaceutical CDMO Industry PESTEL Analysis

Chapter 3: Global Pharmaceutical CDMO Industry Porter's Five Forces Analysis

Chapter 4: Global Pharmaceutical CDMO Major Regional Market Size and Forecast Analysis

Chapter 5: Global Pharmaceutical CDMO Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Pharmaceutical CDMO Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Pharmaceutical CDMO Market Overview

1.1 Product Definition and Statistical Scope

1.2 Pharmaceutical CDMO Product by Type

1.2.1 Global Pharmaceutical CDMO Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 API CDMO

1.2.3 FDF CDMO

1.2.4 Packaging CDMO

1.2.5 Clinical CDMO

1.3 Pharmaceutical CDMO Product by Application

1.3.1 Global Pharmaceutical CDMO Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Chemical Pharmaceutical

1.3.3 Biopharmaceutical

1.3.4 Others

1.4 Global Pharmaceutical CDMO Market Revenue Analysis (2019-2030)

1.5 Pharmaceutical CDMO Market Development Status and Trends

1.5.1 Pharmaceutical CDMO Industry Development Status Analysis

1.5.2 Pharmaceutical CDMO Industry Development Trends Analysis

2 Pharmaceutical CDMO Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Pharmaceutical CDMO Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Pharmaceutical CDMO Market Analysis by Regions

4.1 Pharmaceutical CDMO Overall Market: 2023 VS 2024 VS 2030

4.2 Global Pharmaceutical CDMO Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Pharmaceutical CDMO Revenue and Market Share by Region (2019-2024)

4.2.2 Global Pharmaceutical CDMO Revenue Forecast by Region (2025-2030)

5 Global Pharmaceutical CDMO Market Size by Type and Application

5.1 Global Pharmaceutical CDMO Market Size by Type

5.2 Global Pharmaceutical CDMO Market Size by Application

6 North America

6.1 North America Pharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Pharmaceutical CDMO Market Size by Type

6.4 North America Pharmaceutical CDMO Market Size by Application

6.5 North America Pharmaceutical CDMO Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Pharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Pharmaceutical CDMO Market Size by Type

7.4 Europe Pharmaceutical CDMO Market Size by Application

7.5 Europe Pharmaceutical CDMO Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Pharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Pharmaceutical CDMO Market Size by Type

8.4 China Pharmaceutical CDMO Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Pharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Pharmaceutical CDMO Market Size by Type

9.4 APAC (excl. China) Pharmaceutical CDMO Market Size by Application

9.5 APAC (excl. China) Pharmaceutical CDMO Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Pharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Pharmaceutical CDMO Market Size by Type

10.4 Latin America Pharmaceutical CDMO Market Size by Application

10.5 Latin America Pharmaceutical CDMO Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Pharmaceutical CDMO Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Pharmaceutical CDMO Market Size by Type

11.4 Middle East & Africa Pharmaceutical CDMO Market Size by Application

11.5 Middle East & Africa Pharmaceutical CDMO Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Pharmaceutical CDMO Market Revenue by Key Manufacturers (2020-2024)

12.2 Pharmaceutical CDMO Competitive Landscape Analysis and Market Dynamic

12.2.1 Pharmaceutical CDMO Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Lonza

13.1.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Lonza Pharmaceutical CDMO Product Portfolio

13.1.3 Lonza Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Catalent

13.2.1 Catalent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Catalent Pharmaceutical CDMO Product Portfolio

13.2.3 Catalent Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Thermo Fisher Scientific

13.3.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Thermo Fisher Scientific Pharmaceutical CDMO Product Portfolio

13.3.3 Thermo Fisher Scientific Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Samsung Biologics

13.4.1 Samsung Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Samsung Biologics Pharmaceutical CDMO Product Portfolio

13.4.3 Samsung Biologics Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Fareva

13.5.1 Fareva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Fareva Pharmaceutical CDMO Product Portfolio

13.5.3 Fareva Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 WuXi AppTech

13.6.1 WuXi AppTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 WuXi AppTech Pharmaceutical CDMO Product Portfolio

13.6.3 WuXi AppTech Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 WuXi Biologics

13.7.1 WuXi Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 WuXi Biologics Pharmaceutical CDMO Product Portfolio

13.7.3 WuXi Biologics Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Siegfried

13.8.1 Siegfried Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Siegfried Pharmaceutical CDMO Product Portfolio

13.8.3 Siegfried Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 FUJIFILM Diosynth Biotechnologies

13.9.1 FUJIFILM Diosynth Biotechnologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product Portfolio

13.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Asymchem

13.10.1 Asymchem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Asymchem Pharmaceutical CDMO Product Portfolio

13.10.3 Asymchem Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Pfizer CentreOne

13.11.1 Pfizer CentreOne Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Pfizer CentreOne Pharmaceutical CDMO Product Portfolio

13.11.3 Pfizer CentreOne Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Delpharm

13.12.1 Delpharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Delpharm Pharmaceutical CDMO Product Portfolio

13.12.3 Delpharm Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Recipharm

13.13.1 Recipharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Recipharm Pharmaceutical CDMO Product Portfolio

13.13.3 Recipharm Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 AGC Pharma Chemicals

13.14.1 AGC Pharma Chemicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 AGC Pharma Chemicals Pharmaceutical CDMO Product Portfolio

13.14.3 AGC Pharma Chemicals Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Boehringer Ingelheim

13.15.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Boehringer Ingelheim Pharmaceutical CDMO Product Portfolio

13.15.3 Boehringer Ingelheim Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Vetter

13.16.1 Vetter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Vetter Pharmaceutical CDMO Product Portfolio

13.16.3 Vetter Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Curia

13.17.1 Curia Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Curia Pharmaceutical CDMO Product Portfolio

13.17.3 Curia Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Aenova

13.18.1 Aenova Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Aenova Pharmaceutical CDMO Product Portfolio

13.18.3 Aenova Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Porton

13.19.1 Porton Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Porton Pharmaceutical CDMO Product Portfolio

13.19.3 Porton Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 Piramal

13.20.1 Piramal Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 Piramal Pharmaceutical CDMO Product Portfolio

13.20.3 Piramal Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.21 Strides Pharma

13.21.1 Strides Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.21.2 Strides Pharma Pharmaceutical CDMO Product Portfolio

13.21.3 Strides Pharma Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.22 NextPharma

13.22.1 NextPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.22.2 NextPharma Pharmaceutical CDMO Product Portfolio

13.22.3 NextPharma Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.23 Famar

13.23.1 Famar Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.23.2 Famar Pharmaceutical CDMO Product Portfolio

13.23.3 Famar Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.24 Jubilant

13.24.1 Jubilant Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.24.2 Jubilant Pharmaceutical CDMO Product Portfolio

13.24.3 Jubilant Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.25 Alcami

13.25.1 Alcami Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.25.2 Alcami Pharmaceutical CDMO Product Portfolio

13.25.3 Alcami Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.26 Euroapi

13.26.1 Euroapi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.26.2 Euroapi Pharmaceutical CDMO Product Portfolio

13.26.3 Euroapi Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.27 Eurofins

13.27.1 Eurofins Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.27.2 Eurofins Pharmaceutical CDMO Product Portfolio

13.27.3 Eurofins Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.28 Avid Bioservices

13.28.1 Avid Bioservices Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.28.2 Avid Bioservices Pharmaceutical CDMO Product Portfolio

13.28.3 Avid Bioservices Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.29 BioVectra

13.29.1 BioVectra Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.29.2 BioVectra Pharmaceutical CDMO Product Portfolio

13.29.3 BioVectra Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.30 CPL

13.30.1 CPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.30.2 CPL Pharmaceutical CDMO Product Portfolio

13.30.3 CPL Pharmaceutical CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Pharmaceutical CDMO Industry Chain Analysis

14.2 Pharmaceutical CDMO Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Pharmaceutical CDMO Typical Downstream Customers

14.4 Pharmaceutical CDMO Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support